Balanced Risk-Reward Amid Uneven Demand and Modest AI Upside at Cognizant

Morgan Stanley analyst James Faucette maintained a Hold rating on Cognizant yesterday and set a price target of $82.00.

James Faucette has given his Hold rating due to a combination of factors around Cognizant’s outlook and execution. Management is targeting mid‑single‑digit growth in 2026 with a modest inorganic boost, but this acceleration depends on a stable to slightly improving macro backdrop and continued success in winning and expanding large deals, which still face uneven demand across verticals.

Financial Services and Health Sciences are performing relatively well, yet Products & Resources and Communications & Media remain softer, limiting broad-based momentum. While AI is becoming more embedded in contracts and management is driving incremental margin expansion through productivity and G&A leverage, deal sizes in Gen AI are still modest and gross margins can be volatile around large deal ramps, leading Faucette to see balanced risk‑reward at current valuation rather than a clear catalyst for significant upside.

In another report released on February 27, TipRanks – Anthropic also reiterated a Hold rating on the stock with a $65.00 price target.

CTSH’s price has also changed slightly for the past six months – from $71.450 to $65.120, which is a -8.86% drop .